PRE 14A

PROXY STATEMENT

Company: Eloxx Pharmaceuticals, Inc.
Filed: October 16, 2002
Period of Report: December 13, 2002
Accession Number: 0000903100-02-000311

View Document ↗ View on SEC.gov ↗